Table 1. ALSPAC: The effect of CHRNA5 rs16969968a on the trajectory of smoking quantity during pregnancy is moderated by partner smoking (n=1856).
| Predictor | B | 95% Confidence Interval | P value | |
|---|---|---|---|---|
|
| ||||
| Lower Bound | Upper Bound | |||
| Model 1 | ||||
| Age | -0.0029 | -.047 | .041 | 0.90 |
| Time | -.53 | -.55 | -.50 | <0.0001 |
| Partner smoking | 0.23 | 0.19 | 0.29 | <0.0001 |
| rs16969968a | .070 | .033 | 0.11 | 1.8×10-4 |
|
| ||||
| Model 2 | ||||
| Age | -0.0030 | -0.047 | 0.041 | 0.90 |
| Time | -0.51 | -0.56 | -0.46 | <0.0001 |
| Partner smoking | 0.16 | 0.082 | 0.24 | <0.0001 |
| rs16969968a | 0.078 | 0.021 | 0.14 | 7.8×10-3 |
| rs16969968a * Time | 0.017 | -0.032 | 0.066 | 0.50 |
| Partner smoking* Time | 0.032 | -0.10 | 0.04 | 0.38 |
| Partner smoking* rs16969968a * Timea | 0.071 | 0.013 | 0.13 | 0.017 |
rs1051730 was used as the proxy for rs16969968 (r2=1.0 in 1000G CEU).